Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia
Impact of Combination Therapy Between Hydroxy Urea, Omega 3, Nigella Sativa and Honey on Antioxidant-oxidant Status and Reduction of Iron Overload in Pediatric Major Thalassemia
Sponsor: Beni-Suef Health insurance hospital
A PHASE2/PHASE3 clinical study on Iron Overload and Oxidative Stress, this trial is completed. The trial is conducted by Beni-Suef Health insurance hospital and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Nov 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2025 — Nov 2025 [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
▶ Show 4 earlier versions
-
Feb 2021 — Oct 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Aug 2020 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Nov 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beni-Suef Health insurance hospital
- Beni-Suef University
- Maternity and Children Hospital, Makkah
- University of Arizona
For direct contact, visit the study record on ClinicalTrials.gov .